medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2023, Number 2

<< Back Next >>

Rev Mex Urol 2023; 83 (2)

Bilateral renal tumors: Description of clinicopathological characteristics of synchronous and metachronous presentation, oncological results and associated morbidity

Fuentes-Méndez OA, Gómez-Ortiz D, Gabilondo-Navarro FB, Rodríguez-Covarrubias F

Language: Spanish
References: 13
Page: 1-9
PDF size: 285.89 Kb.


ABSTRACT

Objective: To describe the characteristics of bilateral renal tumors and its impact on postoperative renal function in patients from an institution in Mexico City.
Methods: From March 1980 to May 2021, 17 patients underwent surgery for bilateral renal tumors, 12 were synchronous and the rest metachronous. Oncological and functional characteristics were described.
Results: Mean age was 46.9+/-13.5 years. Four were women and thirteen men. The size of the “first” tumor was 4.85+/-2.59 cm and the “second” was 5.34+/- 3.95 cm. In synchronous tumors, 9 radical and 3 partial nephrectomies were performed for the first tumor and 2 radical and 9 partial for the second tumor (1 patient is still on surveillance for the second tumor). In metachronous patients, 5 radical nephrectomies were performed for the first tumor, and 4 radical and 1 partial for the second tumor. The histological concordance in synchronous and metachronous was 91% and 80%, respectively. The preoperative eGFR was 77.53+30.44 (ml/min/1.73 m2) and postoperative 46.85+38.34, decreasing 35.8% after the second surgery. Follow-up was 88.7+/-44.5 months. Five patients (29.4%) recurred. Overall and disease-free survival were 67.5 and 43 months, respectively.
Conclusions: The histological concordance is in line with previous international reports. Postoperative eGFR decline was more significant in metachronous patients in whom the proportion of radical nephrectomies was higher. Therefore, it highlights the importance of performing partial nephrectomies whenever feasible.


REFERENCES

  1. Padala SA, Barsouk A, Thandra KC, SaginalaK, Mohammed A, Vakiti A, et al.Epidemiology of Renal Cell Carcinoma. WorldJ Oncol. 2020;11(3):79–87. doi: https://doi.org/10.14740/wjon1279

  2. Campbell S, Uzzo RG, Allaf ME, Bass EB,Cadeddu JA, Chang A, et al. Renal Mass andLocalized Renal Cancer: AUA Guideline. JUrol. 2017;198(3):520–9. doi: https://doi.org/10.1016/j.juro.2017.04.100

  3. Yao M, Yoshida M, Kishida T, NakaigawaN, Baba M, Kobayashi K, et al. VHL tumorsuppressor gene alterations associated with goodprognosis in sporadic clear-cell renal carcinoma.J Natl Cancer Inst. 2002;94(20):1569–75. doi:https://doi.org/10.1093/jnci/94.20.1569

  4. Cairns P. Renal cell carcinoma. CancerBiomark. 2010;9(1–6):461–73. doi: https://doi.org/10.3233/cbm-2011-0176

  5. Pantuck AJ, Zisman A, Belldegrun AS. Thechanging natural history of renal cell carcinoma.J Urol. 2001;166(5):1611–23.

  6. Patel MI, Simmons R, Kattan MW, MotzerRJ, Reuter VE, Russo P. Long-term followupof bilateral sporadic renal tumors.Urology. 2003;61(5):921–5. doi: https://doi.org/10.1016/s0090-4295(02)02578-5

  7. Dellavedova T. Tumores renales bilaterales:un desafío quirúrgico. Revista Argentina deUrología. 2011;76(2):41–4.

  8. Becker F, Siemer S, Tzavaras A, SuttmannH, Stoeckle M. Long-term survival in bilateralrenal cell carcinoma: a retrospective singleinstitutionalanalysis of 101 patients after surgicaltreatment. Urology. 2008;72(2):349–53. doi:https://doi.org/10.1016/j.urology.2008.04.001

  9. Blute ML, Itano NB, Cheville JC, Weaver AL,Lohse CM, Zincke H. The effect of bilaterality,pathological features and surgical outcomein nonhereditary renal cell carcinoma. JUrol. 2003;169(4):1276–81. doi: https://doi.org/10.1097/01.ju.0000051883.41237.43

  10. Berczi C, Thomas B, Bacso Z, Flasko T. Bilateralrenal cancers: oncological and functionaloutcomes. Int Urol Nephrol. 2016;48(10):1617–22. doi: https://doi.org/10.1007/s11255-016-1354-4

  11. Rothman J, Crispen PL, Wong Y-N, Al-SaleemT, Fox E, Uzzo RG. Pathologic concordance ofsporadic synchronous bilateral renal masses.Urology. 2008;72(1):138–42. doi: https://doi.org/10.1016/j.urology.2008.01.043

  12. Booth J, Matin SF, Ahrar K, Tamboli P,Wood CG. Contemporary strategies fortreating nonhereditary synchronous bilateralrenal tumors and the impact of minimallyinvasive, nephron-sparing techniques. UrolOncol. 2008;26(1):37–42. doi: https://doi.org/10.1016/j.urolonc.2007.01.012

  13. Simmons MN, Brandina R, Hernandez AV,Gill IS. Surgical management of bilateralsynchronous kidney tumors: functional andoncological outcomes. J Urol. 2010;184(3):865–72; quiz 1235. doi: 10.1016/j.juro.2010.05.042




2020     |     www.medigraphic.com